BioSpace News Archive

BioMidwest

SCORR Marketing and Applied Clinical Trials Release Report on Clinical Research Industry Salary and Employee Satisfaction

SCORR Marketing, a global health science marketing and communications firm, has announced that a new Industry Salary and Employee Satisfaction Survey Report is now available for free download.

January 9, 2018
·
1 min read
Genetown

Lyndra Announces Publication of Feasibility Study of Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy in Nature Communications

Lyndra announced the publication of a feasibility study of an oral, once-weekly drug delivery platform for HIV antiretroviral therapy in the peer-reviewed journal Nature Communications.

January 9, 2018
·
6 min read
Policy

IRIDEX Announces Infringement Lawsuit Against Quantel

The lawsuit alleges that Quantel products infringe U.S. Patent No. 7,771,417, that Quantel breached an earlier agreement between the parties, and that Quantel has infringed Iridex’s MicroPulse trademark, Registration No. 4550188 on the principal register.

January 9, 2018
·
3 min read
Business

Heidelberg Pharma AG and Advanced Proteome Therapeutics Progress Collaborative Program

The companies have agreed to test the combination of APC’s proprietary site-selective protein modification technology and Heidelberg Pharma’s proprietary ATAC technology in order to generate superior cancer therapeutics.

January 9, 2018
·
4 min read
Drug Development

Axsome Tanks as Pain Syndrome Drug Flunks Phase III Study

The CREATE-1 trial was a randomized, double-blind, placebo-controlled Phase 3 trial in patients with CRPS.

January 9, 2018
·
10 min read
Alzheimer’s Research UK Release: Top Dementia Research Charity Calls on Pharma to Stay the Course

Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.

January 9, 2018
·
1 min read
Pharm Country

Cyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018

The company reviewed its 2017 achievements and provided an outline of the Company’s key business objectives for 2018.

January 9, 2018
·
9 min read
Policy

Veritas Pharma Provides Comment on U.S. Attorney General Jeff Sessions Memo

Veritas would like to assure shareholders that it will continue to be committed to advancing the science in medical, not recreational, cannabis in the U.S. states where medical cannabis is legal.

January 9, 2018
·
4 min read
Business

Enigma Biomedical Group Forms Australian Subsidiary To Further Research Efforts

Enigma Biomedical Group today announced the formation of Enigma Biomedical Australia to support it’s ongoing research projects in Australia.

January 9, 2018
·
3 min read
Ossur Hf : Transactions in Relation to Share Buyback Program – Jan. 9, 2018

The purpose of the share buyback program is to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Dividend Policy.

January 9, 2018
·
2 min read